Tyenne® (Tocilizumab-aazg) IV Infusion Therapy

Biosimilar Treatment for Rheumatoid Arthritis and Inflammatory Conditions

Clearwell Infusion Centers offers Tyenne IV infusion therapy for patients with autoimmune and inflammatory diseases. Our Miami-based facility combines private infusion suites, low patient-to-nurse ratios, and ACHC-accredited protocols to provide high-quality care in a comfortable outpatient setting.

What Is Tyenne?

Tyenne® (tocilizumab-aazg) is an FDA-approved biosimilar to Actemra®, designed to treat chronic autoimmune conditions by targeting the interleukin-6 (IL-6) receptor. Blocking IL-6 helps reduce inflammation, prevent joint damage, and improve physical function in several inflammatory disorders.

Tyenne is administered as an intravenous infusion, typically every 4 weeks, depending on the condition and patient response.

Learn more at the official Tyenne website.

Conditions Treated with Tyenne

Tyenne is approved to treat adults and pediatric patients with:

• Rheumatoid Arthritis (RA)
• Polyarticular Juvenile Idiopathic Arthritis (PJIA)
• Systemic Juvenile Idiopathic Arthritis (SJIA)
• Giant Cell Arteritis (GCA)
• Cytokine Release Syndrome (CRS)
• COVID-19-related inflammation in hospitalized patients

It may also be used off-label under a physician’s supervision for other inflammatory conditions.

Tyenne Side Effects

Common side effects of Tyenne may include:

• Headache
• Elevated liver enzymes
• High blood pressure
• Upper respiratory infections
• Infusion reactions
• Increased risk of infections

All Tyenne infusions at Clearwell are monitored by experienced nurses following ACHC-accredited safety protocols.

For full safety information, view the Tyenne Prescribing Information.

Why Choose Clearwell for Your Tyenne Infusion?

When you receive Tyenne therapy at Clearwell Infusion Centers in Miami, you benefit from:

• Private treatment suites with spa-like amenities
• Low patient-to-nurse ratio for attentive care
• Flexible appointment times, including weekends and evenings
• Comprehensive insurance coordination, including prior authorizations and benefits checks
• ACHC-accredited facility and safety standards
• Close coordination with your prescribing provider and care team

Infusions typically last 60 to 90 minutes, depending on your dosage and treatment plan.

Getting Started with Tyenne

If you’ve been prescribed Tyenne, we’ll work directly with your healthcare provider to coordinate care, verify insurance coverage, and start your treatment without delay.

Questions? Call 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

We work with rheumatologists, immunologists, and hospital-based providers to administer Tyenne safely and efficiently.

Why refer to Clearwell?

• Quick benefit verification and prior auth support
• Streamlined referral and intake process
• Timely documentation sent back to your office
• Trusted administration of FDA-approved biosimilars
• ACHC-accredited safety and clinical care

To refer a patient for Tyenne infusion in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.

Looking to start your Tyenne treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you